When should caution be used with regards to histopathologic findings of imaging-guided breast micro- and macro-biopsies?;Quand se méfier des résultats des micro et macrobiopsies guidées mammaires?

Journal de Radiologie

Volumn 87, Issue 3, 2006, Pages 265-273

  Balu Maestro, C ^a   Ettore, F ^a   Chapellier, C ^a   Peyrottes, I ^a   Leblanc Talent, P ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Breast pathology; Imaging guided core breast biopsy; Non malignant breast lesions

Indexed keywords

BIOPSY; BREAST; BREAST BIOPSY; BREAST CANCER; CALCIFICATION; CANCER SCREENING; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; FOLLOW UP; HISTOPATHOLOGY; HYPERPLASIA; IMAGING; REVIEW; SURGICAL TECHNIQUE;

EID: 33645286570     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0221-0363(06)74000-8     Document Type: Article

References (54)

1. Parker SH, Burbank F, Jackman RJ, et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 1994;193:359-64.
2. Kettritz U, Rotter K, Schreer I, et al. Stereotactic vacuum-assisted breast biopsy in 2874 patients. A multicenter study. Cancer 2004;100:245-51.
3. Darling MLR, Smith DN, Lester SC, et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large core needle breast biopsy: Results of surgical excision. Am J Roentgenol 2000;175:1341-6.
4. Burbank F, Parker SH, Fogarty TJ. Stereotactic breast biopsy: improved tissue harvesting with the mammotome. Am Surg 1996;62:738-44.
5. Berg WA, Krebs TL, Campassi C, Magder LS, Sun CCJ. Evaluation of 14-and 11-gauge directional, vacuum-assisted biopsy probes and 14-gauge biopsy guns in a breast parenchymal model. Radiology 1997;205:203-8.
6. Jackman R, Burbank F, Parker SH, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 2001;218:497-502.
7. Liberman L, Dershaw DD, Glassman JR, et al. Analysis of cancers not diagnosed at stereotactic core breast biopsy. Radiology 1997;203:151-7.
8. Burbank F. Mammographic findings after 14-gauge automated needle and 14-gauge directional, vacuum-assisted stereotactic breast biopsies. Radiology 1997;204:153-6.
9. Liberman L, Kaplan JB, Morris EA, Abramson AF, Menell JF, Dershaw VDD. To excise or to sample the mammographic target: what is the goal of stereotactic 11-gauge vacuum-assisted breast biopsy? Am J Roentgenol 2002;179:679-83.
10. Soo MS, Baker JA, Rosen EL. Sonographic detection and sonographically guided biopsy of breast microcalcifications. Am J Roentgenol 2003;180:941-8.
11. Liberman L. Percutaneous imaging-guided core breast biopsy: State of the Art at the Millennium. Am J Roentgenol 2000;174:1191-9.
12. Liberman L, Smolkin JH, Dershaw DD, Morris EA, Abramson AF, Rosen PP. Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy. Radiology 1998;208:251-60.
13. Dershaw DD, Morris EA, Liberman L, Abramson AF. Nondiagnostic stereotaxic core breast biopsy: results of rebiopsy. Radiology 1996;198:323-5.
14. Philpotts LE, Shaheen NA, Carter D, Lange RC, Lee CH. Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versus 14-gauge needle and automatic gun. Am J Roentgenol 1999;172:683-7.
15. Liberman L, Feng TL, Dershaw DD, Morris EA, Abramson AF. US-guided core breast biopsy: use and cost-effectiveness. Radiology 1998;208:717-23.
16. Liberman L, Drotman M, Morris EA, et al. Imaging-Histologic discordance at percutaneous breast biopsy. Cancer 2000;89:2538-45.
17. Jackman RJ, Marzoni FA. Needle-localized breast biopsy: why do we fail? Radiology 1997;204:677-84.
18. Jackman R, Nowels KW, Rodriguez-Soto J, Marzoni FA, Finkelstein SI, Shepard MJ. Stereotactic automated large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term followup. Radiology 1999;210:799-805.
19. Cherel P, Hagay Ch, De Maulmont Ch, Ouhioun O, Plantet MM, Becette V. Macrobiopsies mammaires par aspiration: problémes posés au radiologue. Le Sein 2002;12:130-41.
20. Goodman KA, Birdwell RL, Ikeda DM. Compliance with recommanded followup after percutaneous breast core biopsy. Am J Roentgenol 1998;170:89-92.
21. Liberman L, Benton CL, Dershaw DD, Abramson AF, La Trenta LR, Morris EA. Learning curve for stereotactic breast biopsy: How many cases are enough. Am J Roentgenol 2001;176:721-7.
22. Pfarl G, Helbich TH, Riedl CC, et al. Stereotatic 11 - Gauge Vacuum-assisted breast biopsy: a validation study. Am J Roentgenol 2002;179:1503-7.
23. Jacobs TW, Connolly JL, Schnitt ST. Nonmalignant lesions in breast core needle biopsies. To excise or not to excise? Am J Surg Pathol 2002;26:1095-110.
24. Reynolds HE. Core needle biopsy of challenging. benign breast conditions: a comprehesive literature review. Am J Roentgenol 2000;174:1245-50.
25. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51.
26. Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993;71:1258-65.
27. Yeh IT, Dimitrov D, Otto P, Miller AR, Kahlenberg MS, Cruz A. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen. Arch Pathol Lab Med 2003;127:49-54.
28. Ioffe OB, Berg WA, Silverberg SG, Kumar D. Mammographic-histopathologic correlation oi large-core needle biopsies of the breast. Mod Pathol 1998;11:721-7.
29. Ely KA, Carter BA, Jensen RA, Simpson JF, Page DL. Core biopsy of the breast with atypical ductal hyperplasia. Am J Surg Pathol 2001;25:1017-21.
30. Berg WA, Mrose HE, Ioffe OB. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology 2001;218:503-9.
31. Jackman R, Birdwell RL, Ikeda DM. Atypical ductal hypeplasia: can some lesions be defined as probably benign afte stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision? Radiology 2002;224:548-54.
32. Brem RF, Behrndt VS, Sanow L, Gatewood OMB. Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-Gauge stereotactically guided directional vacuum-assisted biopsy. Am J Roentgenol 1999;172:1405-7.
33. Adrales G, Turk P, Wallace T, Bird R, Norton J, Greene F. Is surgical excision necessary for atypical ductal hyperplasia of the breast diagnosed by mammotome. Am J Surg 2000;180:313-5.
34. e Journées Nationales de la Société Française de Sénologie et de Pathologie Mammaire. Springer 2003:477-82.
35. Kushwaha A, O'Toole M, Sneige N, Stelling CB, Dryden MJ. Mammographic-pathologic correlation of apocrine metaplasia diagnosed using vacuum-assisted stereotactic core-needle biopsy: our 4-year experience. Am J Roentgenol 2003;180:795-8.
36. Warner JK, Kumar D, Berg WA. Apocrine metaplasia: mammographic and sonographic appearances. Am J Roentgenol 1998;170:1375-9.
37. Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 1999;340:430-6.
38. Sloane JP, Mayers MM. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology 1993;23:225-31.
39. Lee CH, Egglin TK, Philpotts L, Mainiero MB, Tocino I. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings. Radiology 1997;202:849-54.
40. Philpotts LE, Shaheen NA, Jain KS, Carter D, Lee CH. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology 2000;216:831-7.
41. Brenner RJ, Jackman RJ, Parker SH, et al. Percutaneous core needle biopsy of radial scars of the breast: when is excision necessary? Am J Roentgenol 2002;179:1179-84.
42. Liberman L, Sama L, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. Am J Roentgenol 1999;173:291-9.
43. Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991;22:1232-9.
44. Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD, Simpson JF. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. The Lancet 2003;361:125-9.
45. Burak WE Jr, Owens KE, Tighe MB, et al. Vacuum-assisted stereotactic breast biopsy: histologic underestimation of malignant lesions. Arch Surg 2000;135:700-703.
46. Foster MC, Helvie MA, Gregory NE, Rebner M, Nees AV, Paramagul C. Lobular carcinoma in situ or atypical lobular hyperplasia at core needle biopsy: is excisional biopsy necessary? Radiology, 2004;231:813-9.
47. Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast:radiologic-pathologic correlation. Am J Roentgenol 2001;176:1255-9.
48. Cohen MA. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why. Radiology 2004;231:617-21.
49. Ottesen GL, Graversen HP, Blichert-Toft M, et al. Lobular carcinoma in situ of the female breast: short-term results of a prospective nationwide study. The Danish Breast Cooperative Group. Am J Surg Pathol 1993;17:14-21.
50. Rosen EL, Bentley RC, Baker JA, Soo MS. Imaging-guided core needle biopsy of papillary lesions of the breast. Am J Roentgenol 2002;179:1185-92.
51. Liberman L, Bracero N, Vuolo MA, et al. Percutaneous large-core biopsy of papillary breast lesions. Am J Roentgenol 1999;172:331-7.
52. Mercado CL, Hamele-Bena D, Koenigsberg T, Spellman EP, Higgins H, Smith SJ. Papillary lesions of the breast: evaluation with stereotactic with stereotactic directional vacuum-assisted biopsy. Radiology 2001;221:650-5.
53. Meyer JE, Smith DN, Lester SC, et al. Large needle core biopsy: nonmalignant breast abnormalities evaluated with surgical excision or repeat core biopsy. Radiology 1998;206:717-20.
54. Carter BA, Page DL, Schuyler P, et al. No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia. Cancer 2001;92:30-6.